The insider selling is concentrated in a single director (Mahoney) and is not a broad C-suite signal. Monitor for any upcoming 8-K or press release that could explain the selling, but the cluster alone does not warrant a bearish stance. The stock's strong momentum and 83% analyst bullish consensus suggest the selling is likely personal portfolio management.
CORT drugs
CORT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 21 $122.25entry
- T+1 · 3mo ago +0.81%α +1.10% · $123.24
- T+5 · 3mo ago −6.85%α −7.32% · $113.88
- T+20 · 8w ago −6.94%α −7.96% · $113.76
- T+60 · due 9h ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider selling at Corcept Therapeutics, led by Director David Mahoney ($12.2M) and CBO Gary Robb ($1.16M), totaling ~$14.8M in open-market sales over a 7-day window. While the dollar amount is significant, the selling is concentrated in a single director (Mahoney) and is likely diversification-driven given the stock's strong performance and $12.9B market cap. The cluster does not signal a material bearish view from the C-suite, as the only C-suite seller (CBO) sold a modest amount relative to market cap (~0.009%).
Key Financial Metrics
Key Facts
- Director David Mahoney sold 103,606 shares for ~$12.2M across four open-market transactions on 2026-08-18.
- CBO Gary Robb sold 10,000 shares for ~$1.16M on 2026-08-17.
- Total insider selling in the cluster is ~$14.8M, representing ~0.11% of CORT's $12.9B market cap.
- The cluster includes one non-cash gift (125 shares by Robb) with no economic value.
- No C-suite CEO or CFO selling; the only C-suite seller (CBO) sold a modest amount.
Financial Impact
Total insider selling of ~$14.8M, or ~0.11% of market cap, modest relative to company size.
Risk Factors
- Director Mahoney's large sale could indicate private concerns not yet public.
- The cluster occurs near all-time highs, raising the risk of a pullback if broader sentiment shifts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CORT-1787292149857 |
Track record
36 reports on CORT
8 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +63.06% at T+60 after the Feb 24, 2026 report. 10 of 11 went positive at some point.
Filters
- Nov 13, 20262d ago Insider Cluster Neutral 2/10 Entry $73.87 Now $69.22 −6.29% settles Dec 15
- Nov 10, 20265d ago 144 Neutral 2/10 Entry $74.53 Now $69.22 −7.12% settles Dec 10
- Nov 4, 202611d ago Insider Cluster Neutral 2/10 Entry $71.63 Now $69.22 −3.36% settles Dec 4
- Nov 3, 202612d ago 8-K Bullish 6/10 Entry $79.22 Now $69.22 −12.62% settles Dec 3
- Nov 2, 202613d ago Institutional Cluster Bearish 4/10 Entry $81.93 Now $69.22 +15.51% settles Dec 2
- Oct 27, 202619d ago SC 13G/A Neutral 3/10 Entry $86.28 Now $69.22 −19.77% settles Nov 25
- Oct 5, 20265w ago Insider Cluster Neutral 3/10 Entry $119.57 to $81.93 Now $69.22 −42.11% ▼ −31.48% −28.30% vs SPY
- Sep 23, 20267w ago 8-K Neutral 3/10 Entry $112.94 to $116.28 Now $69.22 −38.71% ▲ +2.96% +2.27% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.50% vs SPY
- Sep 16, 20268w ago Insider Cluster Bearish 4/10 Entry $114.86 to $113.37 Now $69.22 +39.74% ▲ +1.30% +2.75% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers